136 related articles for article (PubMed ID: 24138094)
1. Collecting and assessing human lactate dehydrogenase-A conformations for structure-based virtual screening.
Buonfiglio R; Ferraro M; Falchi F; Cavalli A; Masetti M; Recanatini M
J Chem Inf Model; 2013 Nov; 53(11):2792-7. PubMed ID: 24138094
[TBL] [Abstract][Full Text] [Related]
2. Screening of novel inhibitors targeting lactate dehydrogenase A via four molecular docking strategies and dynamics simulations.
Sun R; Li X; Li Y; Zhang X; Li X; Li X; Shi Z; Bao J
J Mol Model; 2015 May; 21(5):133. PubMed ID: 25934158
[TBL] [Abstract][Full Text] [Related]
3. Human lactate dehydrogenase a inhibitors: a molecular dynamics investigation.
Shi Y; Pinto BM
PLoS One; 2014; 9(1):e86365. PubMed ID: 24466056
[TBL] [Abstract][Full Text] [Related]
4. Structures of lactate dehydrogenase A (LDHA) in apo, ternary and inhibitor-bound forms.
Kolappan S; Shen DL; Mosi R; Sun J; McEachern EJ; Vocadlo DJ; Craig L
Acta Crystallogr D Biol Crystallogr; 2015 Feb; 71(Pt 2):185-95. PubMed ID: 25664730
[TBL] [Abstract][Full Text] [Related]
5. N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation.
Granchi C; Roy S; De Simone A; Salvetti I; Tuccinardi T; Martinelli A; Macchia M; Lanza M; Betti L; Giannaccini G; Lucacchini A; Giovannetti E; Sciarrillo R; Peters GJ; Minutolo F
Eur J Med Chem; 2011 Nov; 46(11):5398-407. PubMed ID: 21944286
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel lactate dehydrogenase A inhibitors by fragment-based lead generation.
Ward RA; Brassington C; Breeze AL; Caputo A; Critchlow S; Davies G; Goodwin L; Hassall G; Greenwood R; Holdgate GA; Mrosek M; Norman RA; Pearson S; Tart J; Tucker JA; Vogtherr M; Whittaker D; Wingfield J; Winter J; Hudson K
J Med Chem; 2012 Apr; 55(7):3285-306. PubMed ID: 22417091
[TBL] [Abstract][Full Text] [Related]
7. Inhibitor screening of lactate dehydrogenase C4 from black-lipped pika in the Western Sichuan Plateau.
Zhang Q; He Q; Xue F; Ma J
Biosci Biotechnol Biochem; 2014; 78(4):651-4. PubMed ID: 25036963
[TBL] [Abstract][Full Text] [Related]
8. Structure of Toxoplasma gondii LDH1: active-site differences from human lactate dehydrogenases and the structural basis for efficient APAD+ use.
Kavanagh KL; Elling RA; Wilson DK
Biochemistry; 2004 Feb; 43(4):879-89. PubMed ID: 14744130
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 2-((3-cyanopyridin-2-yl)thio)acetamides as human lactate dehydrogenase A inhibitors to reduce the growth of MG-63 osteosarcoma cells: Virtual screening and biological validation.
Cui W; Lv W; Qu Y; Ma R; Wang YW; Xu YJ; Wu D; Chen X
Bioorg Med Chem Lett; 2016 Aug; 26(16):3984-7. PubMed ID: 27406795
[TBL] [Abstract][Full Text] [Related]
10. Computer-aided discovery and biological characterization of human lactate dehydrogenase 5 inhibitors with anti-osteosarcoma activity.
Cao W; Fang L; Teng S; Chen H; Wang Z
Bioorg Med Chem Lett; 2018 Jul; 28(13):2229-2233. PubMed ID: 29861142
[TBL] [Abstract][Full Text] [Related]
11. Fragment growing and linking lead to novel nanomolar lactate dehydrogenase inhibitors.
Kohlmann A; Zech SG; Li F; Zhou T; Squillace RM; Commodore L; Greenfield MT; Lu X; Miller DP; Huang WS; Qi J; Thomas RM; Wang Y; Zhang S; Dodd R; Liu S; Xu R; Xu Y; Miret JJ; Rivera V; Clackson T; Shakespeare WC; Zhu X; Dalgarno DC
J Med Chem; 2013 Feb; 56(3):1023-40. PubMed ID: 23302067
[TBL] [Abstract][Full Text] [Related]
12. Identification of a potent inhibitor targeting human lactate dehydrogenase A and its metabolic modulation for cancer cell line.
Chen CY; Feng Y; Chen JY; Deng H
Bioorg Med Chem Lett; 2016 Jan; 26(1):72-5. PubMed ID: 26597536
[TBL] [Abstract][Full Text] [Related]
13. Cyclophilin A inhibition: targeting transition-state-bound enzyme conformations for structure-based drug design.
Nagaraju M; McGowan LC; Hamelberg D
J Chem Inf Model; 2013 Feb; 53(2):403-10. PubMed ID: 23312027
[TBL] [Abstract][Full Text] [Related]
14. Identification of 2-amino-5-aryl-pyrazines as inhibitors of human lactate dehydrogenase.
Fauber BP; Dragovich PS; Chen J; Corson LB; Ding CZ; Eigenbrot C; Giannetti AM; Hunsaker T; Labadie S; Liu Y; Liu Y; Malek S; Peterson D; Pitts K; Sideris S; Ultsch M; VanderPorten E; Wang J; Wei B; Yen I; Yue Q
Bioorg Med Chem Lett; 2013 Oct; 23(20):5533-9. PubMed ID: 24012183
[TBL] [Abstract][Full Text] [Related]
15. Targeting cancer metabolism to develop human lactate dehydrogenase (hLDH)5 inhibitors.
Zhang SL; He Y; Tam KY
Drug Discov Today; 2018 Jul; 23(7):1407-1415. PubMed ID: 29750903
[TBL] [Abstract][Full Text] [Related]
16. Identification of the first highly selective inhibitor of human lactate dehydrogenase B.
Shibata S; Sogabe S; Miwa M; Fujimoto T; Takakura N; Naotsuka A; Kitamura S; Kawamoto T; Soga T
Sci Rep; 2021 Nov; 11(1):21353. PubMed ID: 34725423
[TBL] [Abstract][Full Text] [Related]
17. On the use of molecular dynamics receptor conformations for virtual screening.
Nichols SE; Baron R; McCammon JA
Methods Mol Biol; 2012; 819():93-103. PubMed ID: 22183532
[TBL] [Abstract][Full Text] [Related]
18. The impact of molecular dynamics sampling on the performance of virtual screening against GPCRs.
Tarcsay A; Paragi G; Vass M; Jójárt B; Bogár F; Keserű GM
J Chem Inf Model; 2013 Nov; 53(11):2990-9. PubMed ID: 24116387
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a docking-based virtual screening platform for the identification of new lactate dehydrogenase inhibitors.
Granchi C; Capecchi A; Del Frate G; Martinelli A; Macchia M; Minutolo F; Tuccinardi T
Molecules; 2015 May; 20(5):8772-90. PubMed ID: 25988609
[TBL] [Abstract][Full Text] [Related]
20. Exploring the Key Amino Acid Residues Surrounding the Active Center of Lactate Dehydrogenase A for the Development of Ideal Inhibitors.
Chen J; Chen C; Zhang Z; Zeng F; Zhang S
Molecules; 2024 Apr; 29(9):. PubMed ID: 38731521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
